The Global Pelvic Floor Electric Stimulator Market Size accounted for USD 228 Million in 2021 and is projected to achieve a market size of USD 562 Million by 2030 rising at a CAGR of 10.7% from 2022 to 2030. Increasing awareness among people will fuel the global pelvic floor electric stimulator market share. In addition, the rising technological advancements and increasing adoption of internet in medical devices are the two popular pelvic floor electric stimulator market trends that are boosting the current industry revenue.

Pelvic Floor Electric Stimulator Market Report Statistics

• Global pelvic floor electric stimulator market revenue is estimated to reach USD 562 Million by 2030 with a CAGR of 10.7% from 2022 to 2030
• North America pelvic floor electric stimulator market share accounted for over 40% shares in 2021
• A regional study in the US found that almost 10% of women have surgery for pelvic organ prolapse, urinary incontinence, or both during their lifetime
• Asia-Pacific pelvic floor electric stimulator market growth will observe fastest CAGR from 2022 to 2030
• Based on application, urinary incontinence accounted for over 84% of the overall market share in 2021
• Increasing cases of urinary incontinence fuels the global pelvic floor electric stimulator market value

Pelvic floor electric stimulator uses a low-grade electrical current that stimulates the muscles to contract and create a muscular response similar to Kegels, an exercise for your pelvic floor muscles. This movement carried out by the device can strengthen pelvic floor muscles, which can ultimately improve urinary frequency, urgency, and incontinence, additionally increasing the strength of the pelvic floor and vaginal muscles.

Global Pelvic Floor Electric Stimulator Market Dynamics

Market Drivers

• Increasing cases of urinary incontinence (UI)
• Rising prevalence of diabetes and hypertension
• Rapid increase in elderly population
• Surge in non-invasive treatments

Market Restraints

• Presence of substitute products
• High cost and strict regulations

Market Opportunities

• Rising adoption of telehealth facilities for pelvic floor care
• Growing technological advancements in healthcare sector

Pelvic Floor Electric Stimulator Market Report Coverage

Market	Pelvic Floor Electric Stimulator Market
Pelvic Floor Electric Stimulator Market Size 2021	USD 228 Million
Pelvic Floor Electric Stimulator Market Forecast 2030	USD 562 Million
Pelvic Floor Electric Stimulator Market CAGR During 2022 - 2030	10.7%
Pelvic Floor Electric Stimulator Market Analysis Period	2018 - 2030
Pelvic Floor Electric Stimulator Market Base Year	2021
Pelvic Floor Electric Stimulator Market Forecast Data	2022 - 2030
Segments Covered	By Product Type, By Application, By End-User, And By Geography
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled	ICON plc, Parexel International, IQVIA, Covance Inc., PRA Health Sciences, LEO Innovation Lab, Medidata Solutions, Oracle Corporation, CRF Health, Clinical Ink, Inc., Medable, Inc., and among others.
Report Coverage	Market Trends, Drivers, Restraints, Competitive Analysis, Player Profiling, Regulation Analysis

Pelvic Floor Electric Stimulator Market Dynamics

The increasing prevalence of urinary incontinence especially among the rising geriatric population is driving the market growth. The increasing awareness initiatives for providing timely solutions to the patients dealing with the issue in daily life are additionally bolstering the market value. The increasing healthcare expenditure and simultaneously developing healthcare infrastructure worldwide and more aggressively in the developing economies is additionally bolstering the market value. The rising demand in home healthcare settings along with the rising awareness is further proliferating the market value. Furthermore, the ongoing investments in R&D for advancing the features of existing devices as well as for developing new devices are driving the market growth.

On the other side, high cost and strict regulations and standards for the approval and commercialization of pelvic floor electric stimulator is likely to limit the growth to an extent over the forecast period from 2022 to 2030.

Pelvic Floor Electric Stimulator Market Segmentation

The worldwide pelvic floor electric stimulator market is split based on product type, application, end-user, and geography.

Pelvic Floor Electric Stimulator Market By Product Type

• Fixed
• Mobile

According to our pelvic floor electric stimulator industry analysis, the fixed product type sub-segment accounted for a significant share of the market in 2021. However, the mobile segment is projected to experience fastest growth over the forecast period from 2022 to 2030 and the segment is also projected to lead the market in the near future. Rapid research & development to produce technological advanced product is supporting the mobile pelvic floor electric stimulator sector.

Pelvic Floor Electric Stimulator Market By Application

• Urinary Incontinence
• Neurodegenerative Diseases
• Sexual Dysfunction

As per the pelvic floor electric stimulator market forecast, urinary incontinence is the prominent application in the global pelvic floor electric stimulator market and the segment is also projected to maintain its dominance from 2022 to 2030. The increasing number of people with urinary incontinence especially among the geriatric population is driving the market growth. Additionally, the increasing awareness about the pelvic floor electric stimulator is further contributing to the market value.

Pelvic Floor Electric Stimulator Market By End-User

• Hospitals & clinics
• Ambulatory Surgical Units
• Home Care Settings
• Others

Hospitals are currently the market leaders with the highest market shares. Hospitals are also expected to maintain their dominance in the coming years. Similarly, hospitals can affect higher investment capabilities and capital, as well as improved access to cutting-edge innovations and patient care, which will boost long-term market growth. On the other hand, home care settings are likely to attain a significant growth rate during the projected timeframe from 2022 to 2030.

Pelvic Floor Electric Stimulator Market Regional Outlook

North America

• U.S.
• Canada

Europe

• U.K.
• Germany
• France
• Spain
• Rest of Europe

Latin America

• Mexico
• Brazil
• Rest of Latin America

Asia-Pacific

• India
• Japan
• China
• Australia
• South Korea
• Rest of Asia-Pacific

The Middle East & Africa (MEA)

• Gulf Cooperation Council (GCC)
• South Africa
• Rest of the Middle East & Africa

Pelvic Floor Electric Stimulator Market Regional Analysis

North America Accounted For the Maximum Revenue Share In 2021

In 2019, the region is having a potential share in the pelvic floor electric stimulator market owing to its advanced healthcare infrastructure and aware population. The major economies of the region including the US and Canada are the major revenue contributors due to their well-established healthcare infrastructure, high-income population, rising geriatric population, and presence of major players. The US is leading the regional market with maximum revenue share.

The Asia-Pacific Is Projected To Exhibit Fastest Growth over the Forecast Period from 2022 To 2030

The major developing economies of the Asia Pacific region are supporting the market growth due to their strong developing economies and the spending power of residents on health issues. The rising awareness about stimulators due to expanding presence of major players in the region is further boosting the regional market value. China is dominating the Asia Pacific region with the maximum share owing to the presence of a number of manufacturers and distributors in the region.

Pelvic Floor Electric Stimulator Market Players

Some of the key pelvic floor electric stimulator companies in the market are ActivLife Technologies, Athena Feminine Technologies, Atlantic Therapeutics, InControl Medical, Laborie Inc., Renovia Inc., TensCare Ltd., The Prometheus Group, Verity Medical Ltd., Zynex Inc., and others.

TABLE OF CONTENT